Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Temporal quantitative phosphoproteomics of ADP stimulation reveals novel central nodes in platelet activation and inhibition.

Beck F, Geiger J, Gambaryan S, Solari FA, Dell'Aica M, Loroch S, Mattheij NJ, Mindukshev I, Pötz O, Jurk K, Burkhart JM, Fufezan C, Heemskerk JW, Walter U, Zahedi RP, Sickmann A.

Blood. 2017 Jan 12;129(2):e1-e12. doi: 10.1182/blood-2016-05-714048.

2.

Oral antiplatelet therapy and platelet inhibition: An experience from a tertiary care center.

Dalal JJ, Digrajkar A, Gandhi A.

Indian Heart J. 2016 Sep - Oct;68(5):624-631. doi: 10.1016/j.ihj.2015.12.022.

3.

Beyond Genetics-Stratified and Personalised Medicines Using Multiple Parameters.

Peck R, Smith P.

Pharmaceuticals (Basel). 2010 May 25;3(5):1637-1651. Review.

4.

Significant Improvement of Antithrombotic Responses to Clopidogrel by Use of a Novel Conjugate as Revealed in an Arterial Model of Thrombosis.

Zhang H, Lauver DA, Wang H, Sun D, Hollenberg PF, Chen YE, Osawa Y, Eitzman DT.

J Pharmacol Exp Ther. 2016 Oct;359(1):11-7. doi: 10.1124/jpet.116.236034.

PMID:
27511819
5.

Effect of long-term adherence to clopidogrel on the VASP-PRI after elective coronary stent implantation: a randomized controlled study.

Forni Ogna V, Menetrey I, Muller O, Tousset E, Guihard L, Fontana P, Eeckhout E, Eap CB, Vrijens B, Burnier M, Wuerzner G.

Br J Clin Pharmacol. 2016 Dec;82(6):1486-1497. doi: 10.1111/bcp.13071.

PMID:
27447737
7.

CYP2C19 loss-of-function alleles are not associated with clinical outcome of clopidogrel therapy in patients treated with newer-generation drug-eluting stents.

Choi IJ, Koh YS, Park MW, Her SH, Choi YS, Park CS, Park HJ, Kim PJ, Chung WS, Kim HS, Shin JG, Seung KB, Chang K.

Medicine (Baltimore). 2016 Jun;95(26):e4049. doi: 10.1097/MD.0000000000004049.

8.

Interactions between Diabetes and the Heart.

Skoularigis J, Melidonis A, Westermann D, Georgiopoulou VV, Karagiannis G, Giamouzis G.

J Diabetes Res. 2016;2016:8032517. doi: 10.1155/2016/8032517. No abstract available.

9.
10.

Efficacy of Clopidogrel and Clinical Outcome When Clopidogrel Is Coadministered With Atorvastatin and Lansoprazole: A Prospective, Randomized, Controlled Trial.

Zhang JR, Wang DQ, Du J, Qu GS, Du JL, Deng SB, Liu YJ, Cai JX, She Q.

Medicine (Baltimore). 2015 Dec;94(50):e2262. doi: 10.1097/MD.0000000000002262.

11.

Personalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfalls.

Winter MP, Koziński M, Kubica J, Aradi D, Siller-Matula JM.

Postepy Kardiol Interwencyjnej. 2015;11(4):259-80. doi: 10.5114/pwki.2015.55596. Review.

12.
13.

Ticagrelor overcomes high platelet reactivity in patients with acute myocardial infarction or coronary artery in-stent restenosis: a randomized controlled trial.

Li P, Yang Y, Chen T, Liu Y, Cao A, Liu J, Wang Z, Zhao X, Qin Y, Ma L.

Sci Rep. 2015 Sep 9;5:13789. doi: 10.1038/srep13789.

14.
15.

Ticagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An Update.

Teng R.

Clin Pharmacokinet. 2015 Nov;54(11):1125-38. doi: 10.1007/s40262-015-0290-2. Review.

16.

Circulating primers enhance platelet function and induce resistance to antiplatelet therapy.

Blair TA, Moore SF, Hers I.

J Thromb Haemost. 2015 Aug;13(8):1479-93. doi: 10.1111/jth.13022.

17.

Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis.

Bellemain-Appaix A, Kerneis M, O'Connor SA, Silvain J, Cucherat M, Beygui F, Barthélémy O, Collet JP, Jacq L, Bernasconi F, Montalescot G; ACTION Study Group..

BMJ. 2014 Oct 24;349:g6269. doi: 10.1136/bmj.g6269. Review.

18.

Comparing of light transmittance aggregometry and modified thrombelastograph in predicting clinical outcomes in Chinese patients undergoing coronary stenting with clopidogrel.

Tang XF, Han YL, Zhang JH, Wang J, Zhang Y, Xu B, Gao Z, Qiao SB, Chen J, Wu Y, Chen JL, Gao RL, Yang YJ, Yuan JQ.

Chin Med J (Engl). 2015 Mar 20;128(6):774-9. doi: 10.4103/0366-6999.152611.

19.

Efficacy and safety of individually tailored antiplatelet therapy in patients with acute coronary syndrome after coronary stenting: a single center, randomized, feasibility study.

Zhu HC, Li Y, Guan SY, Li J, Wang XZ, Jing QM, Wang ZL, Han YL.

J Geriatr Cardiol. 2015 Jan;12(1):23-9. doi: 10.11909/j.issn.1671-5411.2015.01.003.

20.

Prevention of stent thrombosis: challenges and solutions.

Reejhsinghani R, Lotfi AS.

Vasc Health Risk Manag. 2015 Jan 27;11:93-106. doi: 10.2147/VHRM.S43357. Review.

Supplemental Content

Support Center